Skip to main content
. 2020 Jan 6;18:2. doi: 10.1186/s12916-019-1469-4

Table 1.

Selected characteristics at presentation in 21 heart failure patients and healthy donors

Basic information Heart failure patients
n (percentage of 21)
Healthy donors p value
Age (years) 34.6 ± 15.9 41.7 ± 4.0 0.07
Male (percentage) 13 (61.9) 9(100) 0.07
NYHA functional class, n (percentage of 21)
 II 2 (9.5)
 III 7 (33.3)
 IV 12 (57.1)
Comorbidities
 Diabetes mellitus 2 (9.5)
 Smoking history 5 (23.8)
 Pulmonary hypertension 5 (23.8)
 Tricuspid regurgitation 12 (57.1)
 Mitral regurgitation 17 (81.0)
Ultrasonic cardiogram
 LVEF (%) 27.6 ± 9.8
 LA (mm) 44.7 ± 4.8
 IVS-thickness (mm) 8.2 ± 1.1
 LVEDD (mm) 65.1 ± 16.6
Arrhythmia history, n (percentage of 21)
 Atrial fibrillation 4 (19.0)
 Premature ventricular contraction 6 (28.6)
 Ventricular tachycardia 4 (19.0)
 Ventricular fibrillation 1 (4.8)
 CRBBB 3 (14.3)
Drug therapy, n (percentage of 21)
 ASA 2 (9.5)
 Amio 4 (19.0)
 β-Blocker 15 (71.4)
 Digoxin 16 (76.2)
 ACEI/ARB 17 (81.0)
 CCB 3 (14.3)
 Diuretic 18 (85.7)